Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches
International Journal of Molecular Sciences · 31.01.2026 · 27 (3) · 1430
DOI: 10.3390/ijms27031430 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.01.2026. Verfasst von Francisco Navarrete und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, Spain. Hauptthemen laut MEDLINE: Benzodiazepines, Substance-Related Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Plan Nacional Sobre Drogas (PNSD), Ministerio de Sanidad, Red de Investigación en Atención Primaria de Adicciones (RIAPAd), Instituto de Salud Carlos III (ISCIII), Instituto de Investigación Biomedica y Sanitaria de Alicante (ISABIAL).
Abstract (Originalsprache)
Benzodiazepines (BZDs) are globally prevalent psychotropic substances valued for their anxiolytic, hypnotic, anticonvulsant, and myorelaxant properties. Pharmacologically, they act as positive allosteric modulators of the ionotropic GABAA receptor, enhancing inhibitory synaptic transmission. However, prolonged use poses a significant public health concern, risking adverse effects such as cognitive impairment, motor incoordination, tolerance, and physical dependence. The development of tolerance is mediated by complex neurobiological changes, notably the downregulation of GABAA receptor subunits and a compensatory sensitization of excitatory glutamatergic systems. Effective management of established dependence requires comprehensive psychological intervention coupled with pharmacological substitution (switching to a long-acting BZD) and gradual dose tapering. Preventive measures are complex, emphasizing short-term prescriptions, minimum effective dosing, and selecting non-pharmacological or alternative pharmacological agents, such as SSRIs/SNRIs, to mitigate the risk of developing tolerance and dependence. This expert review aims to compile the most relevant, representative, and recent literature summarizing the pharmacology, clinical indications, adverse effects, misuse, and abuse of BZDs that ultimately lead to BZD use disorder (BUD). It also details the involved neurobiological mechanisms and discusses critical preventive and therapeutic strategies, providing readers with the main aspects to consider for addressing this global public health problem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, Spain.
- Red de Investigación en Atención Primaria de Adicciones, Instituto de Salud Carlos III, MICINN and FEDER, 28029 Madrid, Spain.
- Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), 03010 Alicante, Spain.
- Instituto de Investigación (i+12), Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
- Department of Psychiatry, Complutense University of Madrid, 28040 Madrid, Spain.
ORCID-Profile: Francisco Navarrete, Marta Marín-Mayor, Gabriel Rubio, Jorge Manzanares
Förderung
- Plan Nacional Sobre Drogas (PNSD), Ministerio de Sanidad
- Red de Investigación en Atención Primaria de Adicciones (RIAPAd), Instituto de Salud Carlos III (ISCIII)
- Instituto de Investigación Biomedica y Sanitaria de Alicante (ISABIAL)
- Centro de Excelencia Severo Ochoa
- Instituto de Investigación Biomédica y Sanitaria de Alicante
- Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación
Zitieren
APA
Navarrete, F., Marín-Mayor, M., Martínez-Hostyn, L., Rubio, G., & Manzanares, J. (2026). Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches. International Journal of Molecular Sciences, 27(3), 1430. https://doi.org/10.3390/ijms27031430
Vancouver
Navarrete F, Marín-Mayor M, Martínez-Hostyn L, Rubio G, Manzanares J. Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches. International Journal of Molecular Sciences. 2026;27(3):1430. doi:10.3390/ijms27031430
BibTeX
@article{Navarrete2026,
author = {Navarrete, Francisco and Marín-Mayor, Marta and Martínez-Hostyn, Lorena and Rubio, Gabriel and Manzanares, Jorge},
title = {Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {3},
pages = {1430},
doi = {10.3390/ijms27031430}
}
EUVIMED